SkyAI (STSSW) Cash from Investing Activities (2021 - 2025)
Sharps Technology's (STSSW) quarterly Cash from Investing Activities came in at $2.0 million in Q4 2025, up 2747.13% year-on-year from $69659.0 in Q4 2024, and up 101.06% quarter-over-quarter from -$187.5 million in Q3 2025.
SkyAI (STSSW) Cash from Investing Activities (2021 - 2025) Analysis & Trends
Sharps Technology has disclosed Cash from Investing Activities across 5 years of filings, most recently posting $2.0 million for Q4 2025.
- Cash from Investing Activities for Q4 2025 came in at $2.0 million, up 2747.13% year-over-year; the trailing twelve-month figure through Dec 2025 was -$185.5 million (down 18454.36% YoY), and the FY2025 annual result was -$187.5 million, down 18652.27% from the prior year.
- Cash from Investing Activities came in at $2.0 million for Q4 2025 at Sharps Technology, up from -$187.5 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $2.0 million in Q4 2025 to a low of -$187.5 million in Q3 2025.
- The 5-year median for Cash from Investing Activities is -$175955.0 (2022), against an average of -$10.7 million.
- Peak annual rise in Cash from Investing Activities reached 2747.13% in 2025, while the deepest fall reached 372725.75% in 2025.
- Sharps Technology's Cash from Investing Activities stood at -$351758.0 in 2021, then jumped by 50.92% to -$172657.0 in 2022, then sank by 54.58% to -$266898.0 in 2023, then soared by 126.1% to $69659.0 in 2024, then surged by 2747.13% to $2.0 million in 2025.
- The last three Cash from Investing Activities figures came in at $2.0 million (Q4 2025), -$187.5 million (Q3 2025), and $69659.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | SkyAI | 5.15 Mn | -255.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.98 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | -187.55 Mn |
| Sep 30, 2025 | -187.55 Mn |
| Dec 31, 2024 | 69,659.00 |
| Dec 31, 2024 | 69,659.00 |
| Sep 30, 2024 | -50,304.00 |
| Sep 30, 2024 | -50,304.00 |
| Jun 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Mar 31, 2024 | -2,852.00 |
| Mar 31, 2024 | -2,852.00 |
| Dec 31, 2023 | -266,898.00 |
| Dec 31, 2023 | -266,898.00 |
| Sep 30, 2023 | -88,854.00 |
| Sep 30, 2023 | -88,854.00 |
| Jun 30, 2023 | -179,253.00 |
| Jun 30, 2023 | -179,253.00 |
| Mar 31, 2023 | -163,272.00 |
| Mar 31, 2023 | -163,272.00 |